BioGaia Future Growth
Future criteria checks 2/6
BioGaia is forecast to grow earnings and revenue by 3.4% and 10.5% per annum respectively while EPS is expected to grow by 3.3% per annum.
Key information
3.4%
Earnings growth rate
3.3%
EPS growth rate
Biotechs earnings growth | 37.0% |
Revenue growth rate | 10.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 14 Nov 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,593 | 438 | N/A | N/A | 1 |
12/31/2024 | 1,436 | 397 | N/A | N/A | 1 |
12/31/2023 | 1,281 | 356 | N/A | N/A | 1 |
9/30/2023 | 1,273 | 437 | 361 | 396 | N/A |
6/30/2023 | 1,213 | 415 | 311 | 342 | N/A |
3/31/2023 | 1,186 | 413 | 310 | 324 | N/A |
12/31/2022 | 1,104 | 374 | 301 | 319 | N/A |
9/30/2022 | 1,036 | 273 | 262 | 284 | N/A |
6/30/2022 | 952 | 246 | 286 | 305 | N/A |
3/31/2022 | 867 | 222 | 263 | 273 | N/A |
12/31/2021 | 785 | 196 | 215 | 222 | N/A |
9/30/2021 | 767 | 196 | 215 | 220 | N/A |
6/30/2021 | 725 | 164 | 201 | 208 | N/A |
3/31/2021 | 766 | 188 | 177 | 190 | N/A |
12/31/2020 | 747 | 180 | 205 | 221 | N/A |
9/30/2020 | 767 | 194 | 155 | 184 | N/A |
6/30/2020 | 802 | 211 | 155 | 189 | N/A |
3/31/2020 | 780 | 193 | 147 | 185 | N/A |
12/31/2019 | 768 | 187 | 109 | 148 | N/A |
9/30/2019 | 770 | 192 | 133 | 160 | N/A |
6/30/2019 | 778 | 205 | 152 | 174 | N/A |
3/31/2019 | 756 | 207 | 161 | 176 | N/A |
12/31/2018 | 742 | 215 | 170 | 183 | N/A |
9/30/2018 | 702 | 206 | 211 | 223 | N/A |
6/30/2018 | 675 | 197 | 176 | 192 | N/A |
3/31/2018 | 631 | 181 | 158 | 181 | N/A |
12/31/2017 | 615 | 181 | 196 | 223 | N/A |
9/30/2017 | 584 | 179 | 174 | 201 | N/A |
6/30/2017 | 562 | 172 | N/A | 210 | N/A |
3/31/2017 | 542 | 163 | N/A | 198 | N/A |
12/31/2016 | 535 | 160 | N/A | 148 | N/A |
9/30/2016 | 500 | 138 | N/A | 115 | N/A |
6/30/2016 | 480 | 129 | N/A | 86 | N/A |
3/31/2016 | 478 | 130 | N/A | 108 | N/A |
12/31/2015 | 483 | 138 | N/A | 118 | N/A |
9/30/2015 | 500 | 130 | N/A | 100 | N/A |
6/30/2015 | 474 | 119 | N/A | 67 | N/A |
3/31/2015 | 432 | 97 | N/A | 55 | N/A |
12/31/2014 | 482 | 147 | N/A | 124 | N/A |
9/30/2014 | 451 | 146 | N/A | 126 | N/A |
6/30/2014 | 433 | 145 | N/A | 163 | N/A |
3/31/2014 | 426 | 142 | N/A | 167 | N/A |
12/31/2013 | 316 | 62 | N/A | 78 | N/A |
9/30/2013 | 298 | 60 | N/A | 57 | N/A |
6/30/2013 | 299 | 61 | N/A | 25 | N/A |
3/31/2013 | 289 | 61 | N/A | -9 | N/A |
12/31/2012 | 645 | 327 | N/A | 336 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIOGBs's forecast earnings growth (3.4% per year) is above the savings rate (1.5%).
Earnings vs Market: BIOGBs's earnings (3.4% per year) are forecast to grow slower than the UK market (10.3% per year).
High Growth Earnings: BIOGBs's earnings are forecast to grow, but not significantly.
Revenue vs Market: BIOGBs's revenue (10.5% per year) is forecast to grow faster than the UK market (4% per year).
High Growth Revenue: BIOGBs's revenue (10.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BIOGBs's Return on Equity is forecast to be high in 3 years time